In Depth

Narrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbs

The challenges of multiple drugs safety reporting

Pfizer and Takeda deals put a spotlight on value-based pricing

3D printing in drug manufacturing: unlocking future possibilities

Can drug repurposing uncover better treatments for UTIs?

Lethal injection: can pharma kill the death penalty?